Supplementary Materials: Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Pr
QMENTA to exhibit at ECTRIMS in Berlin, RSNA in Chicago & PCT in Barcelona - QMENTA
Alexandre Lemle posted on LinkedIn
ECTRIMS 2022 – Poster, 2022
ECTRIMS by European Committee of Treatment and Research in Multiple Sclerosis
EMSP at ECTRIMS 2016: Delivering for MS communities - EMSP
Previous Congresses - ECTRIMS
ABSTRACT SUBMISSION — ACTRIMS Forum 2024
Highlights From the 2017 Annual European MS Meeting
Congress Report
Dr Marcello Moccia shares his ECTRIMS Fellowship experience - YouTube
Selected Highlights from ECTRIMS – ACTRIMS ppt download
Review of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress 2022 - European Medical Journal
ECTRIMS
ECTRIMS 2019 - Poster Session 3, 2019
Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta® (ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis
ECTRIMS 2017. Un congresso pieno di ricerca e di speranza. | AISM | Associazione Italiana Sclerosi Multipla
Bringing us closer: the global MS research community - World MS Day
ECTRIMS by European Committee of Treatment and Research in Multiple Sclerosis
ECTRIMS 2019 - Poster Session 2, 2019
ECTRIMS by European Committee of Treatment and Research in Multiple Sclerosis
ECTRIMS 2022 – Poster, 2022
Online Library - ECTRIMS
